COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Aug. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2021	Mar. 31, 2021
Weighted average discount rate		8.45%
Weighted average discount rate operating lease		9.11%
Maturity years		6 years 9 months 18 days
Operating lease maturity years		9 years 6 months
Research and development expenses		$ 35,300,000
Net of discount		11,700,000
Finance lease obligations, net of current portion			$ 1,900,000		$ 200,000
Ergomed [Member]
Research and development expenses		200,000	600,000
Clinical service trial		$ 12,000,000
Weighted average time to maturity		7 years 1 month 6 days
Landlord [Member]
Interest rate		0.0845%
Lease description		The repayment includes a base rent which escalates at 3% each year plus interest that accrues at 13.75% per year.
Financing arrangement		$ 11,100,000
Payments made by landlord	$ 2,400,000	$ 1,600,000
October 1, 2019 [Member] | Transaction One [Member]
Weighted average discount rate		8.45%
Current balance		$ 600,000.0		$ 600,000
Net book value of the finance lease right of use asset		12,300,000		12,700,000
Balance of the finance lease liability		13,500,000		13,800,000
Cash paid related to finance leases		600,000	500,000
Cash paid related to finance leases interest		300,000.0	300,000
October 1, 2019 [Member] | Transaction Two [Member]
Current balance		100,000.0		100,000
Cash paid related to operating leases		6,600,000,000	4,800,000,000
Net book value operating lease right of use assets		2,000,000.0		2,100,000
Operating lease - liability		2,100,000.0		$ 2,100,000
Operating lease expense		$ 91,000	$ 66,000